Last reviewed · How we verify

NCT06096376: ULTRAFLOW

Predictors of HFNC Failure in Patients With AHRF Using Diaphragm Ultrasound

Completed Last updated 17 October 2024
What this trial tests

trial testing Diaphragm Ultrasound in Acute Hypoxemic Respiratory Failure in 30 participants. Completed in 1 September 2024.

Timeline
28 April 2023
Primary endpoint
26 June 2024
1 September 2024

Quick facts

Lead sponsorQueen Mary Hospital, Hong Kong
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date28 April 2023
Primary completion26 June 2024
Estimated completion1 September 2024
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

Queen Mary Hospital, Hong Kong

Who can join

Adults 18 to 100, any sex, with Acute Hypoxemic Respiratory Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Ultrasound of the diaphragm is an easily reproducible bedside tool that provides a non-invasive measurement of inspiratory muscle function and respiratory efficiency. The diaphragmatic thickness correlates with the strength and muscle shortening and is reflective of its contribution to the respiratory workload. Diaphragm thickening fraction (DTF) has been shown to be predictive of extubation failure in ventilated patients. However, whether measurements of DTF are predictive of high flow nasal cannula (HFNC) outcomes in patients with acute hypoxemic respiratory failure (AHRF) remains unknown. The objective of this study is to identify predictors of HFNC failure by diaphragm ultrasound and to compare its performance with the well-established ROX index.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Diaphragm Ultrasound

Trials testing the same drug.

Other recruiting trials for Acute Hypoxemic Respiratory Failure

Currently open trials in the same condition.

Other Queen Mary Hospital, Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06096376.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing